ANAB news

Latest 1 stories · newest Sep 21, 2026

ANAB

AnaptysBio Announces Q2 FY2026 Results and Jemperli Updates

Jemperli global net sales rose 34% year-over-year to $644 million. The company reported positive interim results for the AZUR-1 pivotal trial and anticipates a 2027 FDA decision on expansion to rectal cancer.

Earnings Sep 21, 2026 sentiment +0.80 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same ANAB feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/ANAB/newsSTART FREE